Made-In-Singapore Active Pharmaceutical Ingredients get easier access to EU

November 19, 2026 | Thursday | News

Made-in-Singapore APIs for use in human medicines can now be exported to the EU

image credit- shutterstock

image credit- shutterstock

Singapore, through the Health Sciences Authority (HSA), has been recognised by the European Commission for its regulatory framework for active pharmaceutical ingredients (APIs), affirming that its quality oversight of APIs produced in Singapore provides public health protection equivalent to that required in the European Union (EU).

The Commission has adopted a decision that Singapore’s standards and controls on Good Manufacturing Practice (GMP) in Singapore for APIs, which are the active substances responsible for the intended therapeutic effects of medicines, is equivalent to that in the EU. 

Sign up for the editor pick and get articles like this delivered right to your inbox.

+Country Code-Phone Number(xxx-xxxxxxx)

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account